Radiation lethality enhancement with 9-aminocamptothecin: comparison to other topoisomerase I inhibitors. [electronic resource]
- International journal of radiation oncology, biology, physics Sep 1996
- 369-76 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
0360-3016
10.1016/s0360-3016(96)00326-4 doi
Antineoplastic Agents--administration & dosage Camptothecin--administration & dosage Cell Survival--drug effects DNA Topoisomerases, Type I--metabolism Dose-Response Relationship, Radiation Humans Melanoma--enzymology Radiation Tolerance--drug effects Time Factors Topoisomerase I Inhibitors Tumor Cells, Cultured--drug effects